Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Dermatologic Clinics|October 15, 2025
The Current State and Future Prospects for Artificial Intelligence in DermatologyChristopher J Thang, Caitlyn Duffy, Sara Khattab, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Machine learning prediction for early-stage melanoma outcomes: recurrence-free survival, disease-specific survival, and overall survivalGuihong Wan, Hannah Rashdan, Olivia M Burke, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSara Khattab, Guihong Wan, Suzanne Xu, et al.
The British Journal of Dermatology|February 1, 2026
The Impact of Clinicopathologic Features on the Prognosis of Thin Melanomas: A Retrospective Cohort AnalysisEmma Beagles, Sara Khattab, Olivia M Burke, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 13, 2025
Langerhans Cells Directly Interact with Resident T Cells in the Human EpidermisTomonori Oka, Tatsuya Hasegawa, Truelian Lee, et al.
Journal for Immunotherapy of Cancer|May 12, 2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSara Khattab, Guihong Wan, Suzanne Xu, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
SpatialCells: Automated Profiling of Tumor Microenvironments with Spatially Resolved Multiplexed Single-Cell DataGuihong Wan, Zoltan Maliga, Boshen Yan, et al.
Briefings in Bioinformatics|May 3, 2024
SpatialCells: automated profiling of tumor microenvironments with spatially resolved multiplexed single-cell dataGuihong Wan, Zoltan Maliga, Boshen Yan, et al.
Journal of Neuro-Oncology|August 13, 2025
Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cellsMatthew Z Sun, Erick Contreras, Janet Treger, et al.
Nature Communications|May 8, 2024
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II TrialRichard G Everson, Willy Hugo, Lu Sun, et al.
Pageof 2